Please use this identifier to cite or link to this item: doi:10.22028/D291-37470
Volltext verfügbar? / Dokumentlieferung
Title: Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD : Results Of The German COSYCONET Cohort
Author(s): Königsdorfer, Norbert
Jörres, Rudolf A.
Söhler, Sandra
Welte, Tobias
Behr, Jürgen
Ficker, Joachim H.
Bals, Robert
Watz, Henrik
Lutter, Johanna I.
Lucke, Tanja
Biertz, Frank
Alter, Peter
Vogelmeier, Claus F.
Kahnert, Kathrin
Language: English
Title: Patient Preference and Adherence
Volume: 2019
Issue: 13
Pages: 1711-1721
Publisher/Platform: DOVE
Year of Publication: 2019
Free key words: COPD
treatment adherence
respiratory medication
nonrespiratory medication
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Background: Adherence to COPD medication is often considered to be lower than in other chronic diseases. In view of the frequent comorbidities of COPD, the economic impact of nonadherence and the potential for adverse effects, a direct comparison between the adherence to respiratory and nonrespiratory medication in the same patients seems of particular interest. Objectives: We aimed to investigate the intake of respiratory and nonrespiratory medication in the same patients with COPD and frequent comorbidities. Method: Within the COPD cohort COSYCONET, we contacted 1042 patients, mailing them a list with all medication regarding all their diseases, asking for regular, irregular and nonintake. Results: Valid responses were obtained in 707 patients covering a wide spectrum of drugs. Intake of LABA, LAMA or ICS was regular in 91.9% of patients, even higher for cardiovascular and antidiabetes medication but lower for hyperlipidemia and depression/anxiety medication. Regular intake of respiratory medication did not depend on GOLD groups A-D or grades 1–4, was highest in patients with concomitant cardiovascular disorders and was lowest for concomitant asthma. It was slightly larger for LAMA and LABA administered via combined compared to single inhalers, and lower when similar compounds were prescribed twice. Most differences did not reach statistical significance owing to the overall high adherence. Conclusion: Our results indicate a high adherence to respiratory medication in participants of a COPD cohort, especially in those with cardiovascular comorbidities. Compared to the lower adherence reported in the literature for COPD patients, our observations still suggest some room for improvement, possibly through disease management programs.
DOI of the first publication: 10.2147/PPA.S223438
URL of the first publication:
Link to this record: urn:nbn:de:bsz:291--ds-374702
ISSN: 1177-889X
Date of registration: 30-Sep-2022
Faculty: M - Medizinische Fakultät
Department: M - Innere Medizin
Professorship: M - Prof. Dr. Robert Bals
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
There are no files associated with this item.

Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.